Viasys Looks To Spur Growth Through Small Orthopedics Acquisitions
This article was originally published in The Gray Sheet
Executive Summary
Viasys Healthcare aims to lay the groundwork for Medicare reimbursement of its nitric oxide wound care therapy by 2006, when the device is expected to receive FDA approval
You may also be interested in...
Viasys buys Oxford Instruments Medical
Conshohocken, Penn. firm purchases electromyography (EMG) equipment and neurosupplies (EMG needles) maker Oxford for approximately $46 mil., the firms announce March 1. The deal allows Viasys to offer its hospital and physician-office customers a more comprehensive portfolio of single and multi-modality solutions, according to NeuroCare Group President Lori Cross. Oxford also manufactures obstetrics and cardiology products. Viasys, which recorded roughly flat sales of $393.2 mil. in 2004, has been looking to spur revenue growth via small- to medium-scale med-tech acquisitions (1"The Gray Sheet" Feb. 23, 2004, p. 16)...
Investors Go Beserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continue, while companies with governance doubts see shareholders retreat.